BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 9672842)

  • 21. Induction of cleft palate in mice by inhibitors of prostaglandin synthesis.
    Montenegro MA; Palomino H
    J Craniofac Genet Dev Biol; 1990; 10(1):83-94. PubMed ID: 2373758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative variation in hormonal receptors and clefting in the mouse.
    Goldman AS; Katsumata M
    Prog Clin Biol Res; 1980; 46():91-120. PubMed ID: 7022463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Backcross test demonstrates the linkage of glucocorticoid-induced cleft palate susceptibility to H-2.
    Bonner JJ; Tyan ML
    Teratology; 1982 Oct; 26(2):213-6. PubMed ID: 7157197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cortisone-induced cleft palate in A/J mice: failure of palatal shelf contact.
    Diewert VM; Pratt RM
    Teratology; 1981 Oct; 24(2):149-62. PubMed ID: 7336358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restriction fragment length polymorphisms, glucocorticoid receptors, and phenytoin-induced cleft palate in congenic strains of mice with steroid susceptibility differences.
    Gasser DL; Goldner-Sauvé A; Katsumata M; Goldman AS
    J Craniofac Genet Dev Biol; 1991; 11(4):366-71. PubMed ID: 1687470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered expression of retinoic acid (RA) receptor mRNAs in the fetal mouse secondary palate by all-trans and 13-cis RAs: implications for RA-induced teratogenesis.
    Naitoh H; Mori C; Nishimura Y; Shiota K
    J Craniofac Genet Dev Biol; 1998; 18(4):202-10. PubMed ID: 10100049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetics of susceptibility to 6-aminonicotinamide-induced cleft palate in the mouse: studies in congenic and recombinant inbred strains.
    Karolyi J; Erickson RP; Liu S
    Teratology; 1988 Mar; 37(3):283-7. PubMed ID: 2966993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentiation of triamcinolone-induced cleft palate in mice by maternal high dietary fat.
    Zhou M; Walker BE
    Teratology; 1993 Jul; 48(1):53-7. PubMed ID: 8351648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination therapy with folic acid and methionine in the prevention of retinoic acid-induced cleft palate in mice.
    Reynolds PR; Schaalje GB; Seegmiller RE
    Birth Defects Res A Clin Mol Teratol; 2003 Mar; 67(3):168-73. PubMed ID: 12797458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin B12 counteracts dexamethasone-induced proliferation and apoptosis during key periods of palatogenesis in mice.
    He W; Meng T; Lu SJ; Zheng Q; Li CH; Wu M; Shi B
    Ann Plast Surg; 2010 Apr; 64(4):466-70. PubMed ID: 20224330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of dose-response relationships to discriminate between the mechanisms of cleft-palate induction by different teratogens: an argument for discussion.
    Biddle FG
    Teratology; 1978 Oct; 18(2):247-52. PubMed ID: 715728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T1Wh, a promising mouse strain with chromosomal markers for cleft palate research.
    Miller KK; Atnip RL
    Teratology; 1977 Aug; 16(1):41-6. PubMed ID: 898090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. H-2 histocompatibility region influences the inhibition of arachidonic acid cascade by dexamethasone and phenytoin in mouse embryonic palates.
    Gupta C; Katsumata M; Goldman AS
    J Craniofac Genet Dev Biol; 1985; 5(3):277-85. PubMed ID: 4044790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cleft palate induction in hamster fetuses by glucocorticoid hormones and their synthetic analogues.
    Shah RM; Kilistoff A
    J Embryol Exp Morphol; 1976 Aug; 36(1):101-8. PubMed ID: 978122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinants in the H-2S/H-2D interval of mouse chromosome 17 define the map position of a gene for cleft palate susceptibility.
    Gasser DL; Yadvish KN; Trammell MA; Goldman AS
    Teratology; 1988 Dec; 38(6):571-7. PubMed ID: 3238613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of neurotransmitters in palate development and teratologic implications.
    Zimmerman EF
    Prog Clin Biol Res; 1985; 171():283-94. PubMed ID: 2858863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epithelial alterations of secondary palate formation.
    Bittencourt MA; Bolognese AM
    Braz Dent J; 2000; 11(2):117-26. PubMed ID: 11210260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of RXR-alpha in retinoic acid-induced cleft palate as assessed with the RXR-alpha knockout mouse.
    Nugent P; Sucov HM; Pisano MM; Greene RM
    Int J Dev Biol; 1999 Sep; 43(6):567-70. PubMed ID: 10610030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study of craniofacial growth during secondary palate development in four strains of mice.
    Diewert VM
    J Craniofac Genet Dev Biol; 1982; 2(4):247-63. PubMed ID: 7183704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Investigation on Dexamethasone induced cleft palate in embryos of C57BL/6J mice by 1H-NMR pattern recognition of metabolites group].
    Xu B; Zhou J; He W; Lu S; Kong X; Shi B; Huang J; Li W
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Apr; 26(2):366-70. PubMed ID: 19499804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.